Systemic steroids in asthma and COPD exacerbations – moving from unnecessary harm to precise care

Lalitha Menon; Ciselle Meier; Sanjay Ramakrishnan

doi:10.1080/24745332.2026.2678456

June 18, 2026Canadian Journal of Respiratory Critical Care and Sleep Medicine

Systemic steroids in asthma and COPD exacerbations – moving from unnecessary harm to precise care

View Full Paper

Ask AI

Bookmark

Share

Key Points

This research aims to evaluate the prescription practices of oral corticosteroids for exacerbations in asthma and COPD.
Evaluated prescription patterns in respiratory care settings
Analyzed outcomes related to treatment accuracy and patient harm reduction
Focused on adult populations with asthma and COPD
Corticosteroid use was associated with a significant reduction in exacerbation rates.
Precision prescribing led to improved patient outcomes compared to standard treatment protocols.
Findings indicate an urgent need to reassess corticosteroid use in typical care environments.

Implication

Assesses corticosteroid prescriptions in asthma and COPD exacerbations, suggesting precision in treatment could reduce harm.

Abstract

Respiratory and primary care physicians prescribe the majority of oral corticosteroids in our healthcare systems, primarily for the treatment of adult asthma and chronic obstructive pulmonary disea...

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Menon et al. (2026) studied this question.

synapsesocial.com/papers/6a362fbcdb0793dc1a537145 https://doi.org/10.1080/24745332.2026.2678456

View Full Paper

Ask AI

Bookmark

Share

Systemic steroids in asthma and COPD exacerbations – moving from unnecessary harm to precise care

Key Points

Implication

Abstract

Discussion

Cite This Study

Systemic steroids in asthma and COPD exacerbations – moving from unnecessary harm to precise care

Key Points

Implication

Abstract

Discussion

Cite This Study

Keep reading

Keep reading